Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson’s disease by unknown
Kim et al. BMC Neurology 2013, 13:127
http://www.biomedcentral.com/1471-2377/13/127CASE REPORT Open AccessUnusual epileptic deterioration and extensive
white matter lesion during treatment in Wilson’s
disease
Young Eun Kim1,2, Ji Young Yun2,3, Hui-Jun Yang2,4, Han-Joon Kim2,5 and Beom S Jeon4*Abstract
Background: Wilson’s disease (WD) is a genetic disorder which can be controlled fairly well with decupuration
therapy. However, symptoms, on rare occasions, can worsen even when WD is being treated. Herein, we report a
case involving unusual neurological deterioration during decupuration therapy for WD.
Case presentation: A 28-year-old man was diagnosed with WD 13 years prior to his clinical visit; however, his drug
compliance has been poor over the years. He was treated with trientine because tremors and dysarthria have
presented in recent years. However, dysarthria and dystonia developed in his limbs, which were worse on the right
side and had been aggravated for several weeks despite good drug compliance. His symptoms were fluctuating. It
was initially misdiagnosed as dystonia; although, it turned out to be a seizure due to cortical degeneration. These
symptoms were completely resolved with antiepileptic drugs. Moreover, the cortical enhancement of bifrontal
degeneration has disappeared on the MRI.
Conclusion: This case showed unusual epileptic neurologic deterioration due to cortical degeneration during
decupuration therapy. Seizures in WD can easily be mistaken as part of dystonia. However, the fluctuating
symptoms suggest a seizure.
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Wilson disease (WD) is a disorder involving copper meta-
bolism characterized by impaired excretion of this metal
[1]. Neurological worsening during decupuration therapy
may be due to the side effects of the drug, improper treat-
ment, poor drug compliance, drug resistance, or fulminant
disease [2,3]. This case shows unusual neurological deteri-
oration and cortical degeneration during decupuration
therapy for WD.Case presentation
A 28-year-old male was diagnosed with WD in 1997, when
he was 15 years old. Kayser-Fleischer ring was found inci-
dentally during ophthalmological examination for itchy
eyes. The serum ceruloplasmin was 3.5 mg/dl (normal
range 15-40); the serum copper was 38 ug/dl (normal range* Correspondence: brain@snu.ac.kr
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reproduction in any medium, provided the or70-155); and the 24 hour urine copper was 1620 ug/day
(normal range 0-75). Abdominal sonography showed
chronic liver disease and brain MRI was compatible with
WD; however, he did not have hepatic or neurological
symptoms at that time. As the treatment regime, Penicilla-
mine was tried initially, and then, it was switched to
trientine because of the side effects such as paresthesia.
Compliance was poor for 10 years because he did not have
any symptoms. In late 2009, tremors and behavioral
changes including irritability, aggressive behavior, and a
somewhat depressive mood developed and became pro-
gressively worse. He visited our clinic in May 2010. Dys-
tonic tremor in the right hand and mild dysarthria was the
main feature upon initial examination. The serum cerulo-
plasmin was repeatedly less than 8 mg/dl; the serum copper
was 37.3 ug/dl, and the 24 hour urine was 630 ug/day.
Kayser-Fleischer ring was present. Trientine was prescribed
with a gradual increase to 1000 mg; however, he
complained of worsening stuttering, tremor, and gait dis-
turbance for the next several months, and more aggravation. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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good compliance in taking his meds.
He was admitted to the hospital to evaluate his deteri-
oration in September 2010.
Upon admission, he had dysarthria, stuttering, and bi-
lateral dystonic movements in the limbs, which were
worse on the right side. Neurological examination
showed mild motor impairment, brisk deep tendon re-
flexes, and extensor plantar responses, mainly on the
right leg. His speech disturbance and dystonia had pecu-
liar fluctuations with intermittent worsening without
change of alertness lasting from several minutes to an
hour, and occurring many times a day (Additional file 1).
At times, he became almost anarthric and unable to
move the affected parts with stiffening. In general, his
neurological condition progressively deteriorated with
the above mentioned intermittent worsening during
his hospital stay. Blood and urine studies showed
good compliance for his medication (serum copper was
16.5 ug/dL and 24 hour urine copper was 613 ug/day).
Brain MRI was done after we confirmed above neuro-
logic findings and showed high signal intensity lesions
on the bilateral paramedian superior frontal gyri as well
as on the basal ganglia, thalamus, and brain stem on T2,
Flare, and DWI. Contrast enhancement was present on
the left superior frontal gyrus (see Figure 1A).
Video EEG monitoring showed multiple episodes of stif-
fening of the right arm followed by dystonic then rhythmic
tremor of the right leg, which correlated with the left
frontal rhythmic delta activity (Additional file 2).
Levetiracetam 2500 mg and Trileptal 1200 mg markedly
improved his neurological symptoms. Upon brain MRI,
cortical enhancement almost disappeared one month after
antiepileptic medications (see Figure 1B).Figure 1 The change of MRI over time (A) MRI before the treatment w
both paramedian superior frontal gyri, both basal ganglia and thalam
superior frontal gyrus in the T1 enhanced image. (B) Cortical enhancem
with the antiepileptics.Conclusions
This case presented unusual epileptic neurological deterio-
ration in WD. Flutuating deterioration of focal neurologic
deficit during decupuration can be mistaken as a part of
dystonia in WD because dystonia is usually aggravated on
action and it is rather common in WD. However, fluctua-
ting symptoms suggested seizures in this case. Seizure
should be considered as one of the causes of neurologic
deterioration in WD.
The seizures are probably related to Wilsonian cortical
damages in this case. The resolution of the neurological
symptoms and cortical enhancement after antiepileptic
medication suggests that there were secondary cortical
changes following the seizures.
WD with extensive white matter lesions represents a rare
neuropathological subgroup, the pathogenesis of which is
not clearly determined [4-7]. These abnormalities occur
mainly in the frontal lobe [5]. And most of the patients with
extensive WML were non-treated patients with a very se-
vere form of the disease, and had very poor prognosis [4].
Epilepsy is not a common manifestation of WD, but is
present and more common in a WD population with
WML rather than just the general WD population [6,7].
However there have been no reports on seizures provoking
a secondary change of the WML in WD or on the reso-
lution of the cortical enhancement following AED. Based
on the chronological changes on MRI in our case, seizures
appear to have contributed to extensive WML and cortical
enhancement.
Epilepsy may mimic dystonia when the spells cause
posturing. Nocturnal paroxysmal dystonia, which was
previously misclassified as primary movement disorder,
is now recognized to be a manifestation of nocturnal
frontal lobe epilepsy [8]. De Silva et al. reported thatith antiepileptics after admission shows high signal intensity on
us in the FLARE image, and cortical enhancement on the left
ent of left superior frontal gyrus resolved at 1 month after treatment
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focal epilepticus [9]. Our case showed paroxysmal and
fluctuating spasms, which prompted us to suspect epi-
lepsy. Early suspicion and diagnosis of seizures can pre-
vent the secondary generalization and complications.
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Additional file 1: Segment 1 shows dysarthria and bilateral
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